⌘K

Home/Filings/4/0001161697-18-000620

4//SEC Filing

BRENNAN DANIEL 4

Accession 0001161697-18-000620

CIK 0001369568other

View on SEC.gov Company Profile

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 4:46 PM ET

Size

9.6 KB

Accession

0001161697-18-000620

Insider Transaction Report

Form 4

Period: 2018-12-19

CATALYST PHARMACEUTICALS, INC.CPRX

Chief Commercial Officer

Transactions

Award
Options to purchase common stock
2018-12-19+38,333→ 476,666 total
Exercise: $2.24From: 2020-12-19Exp: 2025-12-19→ Common Stock (38,333 underlying)
Award
Options to purchase common stock
2018-12-19+38,333→ 438,333 total
Exercise: $2.24From: 2019-12-19Exp: 2025-12-19→ Common Stock (38,333 underlying)
Award
Options to purchase common stock
2018-12-19+38,334→ 515,000 total
Exercise: $2.24From: 2021-12-19Exp: 2025-12-19→ Common Stock (38,334 underlying)

Documents

1 file

4
form4.xmlPrimary
FORM 4 FOR 12-19-2018

Issuer

CATALYST PHARMACEUTICALS, INC.

CIK 0001369568

Entity typeother

Related Parties

1

filerCIK 0001657999

Filing Metadata

Form type: 4
Filed: Dec 20, 7:00 PM ET
Accepted: Dec 21, 4:46 PM ET
Size: 9.6 KB

View on SEC.gov